Salivary carcinoma in HER-2/neu transgenic male mice: an angiogenic switch is not required for tumor onset and progression.

Diodoro, M G; Di Carlo, E; Zappacosta, R; Iezzi, M; Coletti, A; Modesti, A; D'Antuono, T; Forni, G; Musiani, P

Diodoro, M G; Di Carlo, E; Zappacosta, R; Iezzi, M; Coletti, A; Modesti, A; D'Antuono, T; Forni, G; Musiani, P.

Affiliation

Diodoro MG; Department of Oncology and Neurosciences, G. D'Annunzio University, Chieti, Italy.

Int J Cancer ; 88(3): 329-35, 2000 Nov 01.

Article in En | MEDLINE | ID: mdl-11054659

Subject(s)

Neovascularization, Pathologic/pathology; Receptor, ErbB-2/physiology; Salivary Gland Neoplasms/blood supply; Animals; Apoptosis; Endothelial Growth Factors/analysis; Female; Hyperplasia; Immunohistochemistry; Lymphokines/analysis; Male; Mice; Mice, Inbred BALB C; Mice, Transgenic; Reverse Transcriptase Polymerase Chain Reaction; Salivary Gland Neoplasms/etiology; Salivary Gland Neoplasms/pathology; Salivary Glands/pathology; Salivary Glands/ultrastructure; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Salivary Gland Neoplasms / Receptor, ErbB-2 / Neovascularization, Pathologic Type of study: Etiology_studies Limits: Animals Language: En Journal: Int J Cancer Year: 2000 Document type: Article Affiliation country: Italy

Search on Google

Add to My VHL

XML

PubMed Links